Study on Bortezomib and Drug Combination for Children with High-Risk Relapsed Acute Lymphoblastic Leukemia (ALL)
- Substances:BortezomibDexamethasone+4
Germany- Participants:0–17 years
- Substances:Bortezomib
Rare diseases
Investigational molecules
Locations
GermanyStudy to Test if Zelpultide Alfa Helps Prevent Lung Disease in High-Risk Premature Babies
GermanyStudy on Ruxolitinib and Methoxsalen for Patients with Steroid-Refractory Chronic Graft-versus-Host Disease
GermanyStudy on Atezolizumab and Bevacizumab for Patients with Intermediate-Stage Liver Cancer
GermanyStudy of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine
GermanyStudy on the Effectiveness of Oxaliplatin or Gemcitabine Chemotherapy in Patients with Resected Pancreatic Cancer Using Standard or Genetic Allocation Methods
GermanyStudy on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
GermanyStudy on Stereotactic Cisternal Lavage Therapy for Patients with Aneurysmal Subarachnoid Hemorrhage Using Urokinase, Nimodipine, and a Drug Combination
GermanyStudy on Ependymoma Treatment in Children, Adolescents, and Young Adults Using Cisplatin, Cyclophosphamide, Etoposide, and a Drug Combination
GermanyStudy on Chemotherapy with Irinotecan, Fluorouracil, and Oxaliplatin for Patients with Metastatic Colorectal Cancer After Surgery or Ablation
GermanyStudy of drug combinations including irinotecan, ifosfamide, vincristine, dactinomycin, regorafenib and other agents for children and adults with rhabdomyosarcoma
GermanyLong-term safety study of oral etavopivat tablets in children, adolescents and adults with sickle cell disease or thalassaemia who completed previous etavopivat treatment
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.